EMISFLOX

This brand name is authorized in Nigeria.

Active ingredients

The drug EMISFLOX contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-100817	Tablet	Emisflox 500 mg Tablet TAB 500 mg 1 x 10's (in Alu-Alu blister)	Film coated tablets White color, plain on both side, 17x8 mm oval shape Emisflox 500mg Tablet Ciprofloxacin BP 500mg CIPROFLOXACIN HCL 500MG, MAIZE STARCH, MAGNESIUM STEREATE, PVPK30, MICROCRYSTALLINE CELLUOSE POWDER, SODUM STRACH GLYCOLATE, CITRIC ACID, AEROSIL Drugs Nigerian Products 1x10Tab 10-07-2024 ARTEMIS LABORATORIES LTD, PLOT 4, BLOCK 4, OGUN STATE HOUSING CORPORATION AND INDUSTRIAL ESTATE, OTA, Ado-Odo/Ota, OGUN 08033198927 regulatoryaffairs@artemislife.com Artemis Laboratories Limited, Plot 4, Block 4, Ogun State Housing Corporation and Industrial Estate, Ota, Ogun State, Nigeria	28/02/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-100817